Department of Obstetrics and Gynecology Archives
Feb. 11, 2021—The Vanderbilt Maternal Addiction Recovery Program (VMARP) is offering virtual appointments to help reach patients in Nashville’s outlying areas for treatment of Opioid Use Disorder (OUD).
Sep. 2, 2020—Access to women’s health and midwifery services is now more convenient than ever for Lebanon and Wilson County residents with the opening of the new Center for Women’s Health Lebanon outpatient clinic, set to open Sept. 9.
Jul. 30, 2020—Katherine Hartmann, MD, PhD, Associate Dean for Clinical and Translational Scientist Development, has been named Vice President for Research Integration for Vanderbilt University Medical Center.
Jun. 9, 2020—Women who are prescribed opioids after childbirth have an increased risk of persistent opioid use or other serious opioid-related events, including overdose, in their first year postpartum, according to a new study by Vanderbilt University Medical Center researchers. This is true regardless of whether the woman had a vaginal delivery or a cesarean section.
Mar. 10, 2020—To provide additional maternity care and a full spectrum of birthing experience options for patients, Vanderbilt University Medical Center has announced plans to acquire the Nashville location of Baby+Company, a freestanding birthing center that emphasizes a family-centered, low-intervention approach to delivery for uncomplicated pregnancies.
Mar. 4, 2020—Hearing that she could deliver her second child with no out-of-pocket expense convinced Vanderbilt University Medical Center employee Amy New to enroll in the new MyMaternityHealth Bundle offered by Vanderbilt Health, and she quickly learned the program’s advantages didn’t stop there.
Dec. 5, 2019—The Vanderbilt Maternal Addiction Recovery Program is participating in a 12-site clinical trial that will compare two forms of the medication buprenorphine in treating opioid use disorder during pregnancy, and the results could have a potentially significant impact on clinical practice.
Sep. 19, 2019—Vanderbilt researchers hope to identify factors that may make humans more susceptible to toxicant exposure — specifically the presence of pre-existing inflammatory disease.